Paul Hofman

44PUBLICATIONS
366CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 20, 2026
Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy.

|Jul 03, 2026
Spatial transcriptomic atlas of aggressive osteosarcomas reveals shared immune landscape and targetable surface markers.

|Apr 29, 2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

|Apr 22, 2026
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

|Nov 25, 2025
Combined neuroendocrine tumor and goblet cell adenocarcinoma of the appendix: a distinct entity? Insights from three new cases.

Laurent Doucet, Stéphanie Patouraux, Mohamed-Amine Bani

|Aug 06, 2025
Collagenous colitis in patients treated for cancer: role of immune checkpoint inhibitors. Clinical, histological and immunological features in 15 cases.

Mohamed-Amine Bani, Peggy Dartigues, Ranya Soufan

Pageof 8

Frequent Collaborators

8 joint publications

Benjamin Besse

6 joint publications

Fabrice André

6 joint publications

Lambros Tselikas

6 joint publications

Yohann Loriot